Tag: Atrial Fibrillation
Dual Therapy Noninferior to Triple Therapy for A-Fib With PCI
And lower risk of bleeding with dabigatran and P2Y12 inhibitor dual therapy versus triple therapy
Study Highlights Readmit Factors Post Atrial Flutter Ablation
Readmission rate found to be 18.19 percent
Most Common Arrhythmia: Intra-Atrial Re-Entrant Tachycardia
Among those age ≥50 years, atrial fibrillation increased with age to surpass IART as most common
Reduced eGFR, Increased UACR Linked to Incident A-Fib
Step-wise increase in adjusted risk of incident atrial fibrillation across categories of decreasing eGFR
Long Working Hours May Increase Risk of Developing A-Fib
Could help explain previously observed increased risk of stroke among those working long hours
Rivaroxaban OK for Stroke Prevention in Cancer Patients
Safety, efficacy in cancer patients similar to the general population
Advanced Practice Provider Can Safely Perform Cardioversion
Trained and credentialed APP can perform electric cardioversion for atrial fibrillation
Robotic Navigation Noninferior for CVPI in Atrial Fibrillation
Longer procedure times with robotic ablation, but noninferior in terms of success, complications
Better Outcomes for Cardiology Care in Newly Diagnosed A-Fib
Reduction in stroke, death; increase in hospitalization for AF/SVT, MI
VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib
Vitamin K antagonist + acetylsalicylic acid dual therapy associated with increased bleeding risk
